1. Home /
  2. Biotechnology


2 Small Biotechs With Sagging Shares but Promising Prospects

The stocks of these two developmental concerns have slid recently, but there are reasons to believe they will improve.

Blindly Following the Consensus Is Rarely the Right Course of Action

That's why I always act incrementally when allocating new funds to the market or raising cash in my portfolio.

Stalking Entry Points in the XBI Biotech ETF

Plus an update on my SPX and Nike plays.

Mirati Therapeutics Could Soar Even Higher

Prices went vertical early this month on heavy volume.

A Six-Pack of Biotech Best Bets

Ironically, some experts now see biotech as a safe haven as the sector remains unaffected by trade wars and other global headwinds.

Amgen Charts Indicate Bounce Possible Within a Longer-Term Downtrend

In the short run the stock of this biotech giant could bounce as momentum has slowed, but the bigger picture is for further weakness.

These 3 Biotech Stocks Are Attracting Insider Buying

What are insiders buying as the market sells off in recent trading sessions?

2 Biotech Names See Directors Direct Cash to Their Shares

The stock purchases by the insiders are at companies developing treatments for breast cancer and schizophrenia.

Hopeful Signs for These 2 Small Biotech Stocks

Few parts of this biotech space are more frustrating that what I have dubbed 'Tier 3' biotech concerns.

Here's How I'm Playing an Increasingly Volatile Market With These 2 Biotechs

I am incrementally using buy-write option orders to add some shares to core holdings.